Data / Medical devices / Switzerland / Teoxane S.A.

Teoxane S.A.: FDA-registered device maker in Geneva Geneve, Switzerland, 1 PMA approval

Teoxane S.A. is registered with the FDA (registration 3005975625) in Geneva Geneve, Switzerland. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated October 19, 2017. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number

3005975625

Address

Les Charmilles 105 rue de Lyon, Geneva Geneve, Switzerland, CH-1203

Owner or operator

Teoxane S.A. (10056277)

Roles

Complaint file establishment, Manufacturer

First device listed

November 22, 2017

Registered through

2026

Brand names listed

RHA Redensity®, RHA Redensity® Eye, RHA Redensity® Eye Lido, RHA Redensity® Mepi, RHA® 2, RHA® 2 Mepi, RHA® 3, RHA® 3 Mepi and more

Devices it lists

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

Compare with other makers

• All makers of Implant, Dermal, For Aesthetic Use

Updated August 31, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.